ASTRAZENECA DL-,25 SP.ADR revenue breakdown overview

ASTRAZENECA DL-,25 SP.ADR revenue for the last year amounted to 41.51 B EUR, the most of which — 15.53 B EUR — came from its highest performing source at the moment, Oncology, the year earlier bringing 13.67 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought ASTRAZENECA DL-,25 SP.ADR 16.42 B EUR, and the year before that — 16.14 B EUR.